CDXS
Codexis, Inc.
stockNASDAQ
codexis, inc. is a leading protein engineering company applying innovative technologies to unlock the power of proteins™. our proprietary codeevolver® technology platform enables the rapid development and production of highly optimized proteins, custom-designed for your application. codexis' revolutionary approach to protein engineering starts with an understanding of the desired performance specifications and optimizes a protein specifically to fit these requirements. you get precisely the protein you need for the job you want it to do. guided by proprietary artificial intelligence software and advanced high-throughput screening systems, codexis is able to efficiently generate and introduce function-driven mutations to rapidly improve a protein for its target application. since 2002, codexis' in-house biochemists, biologists and bioinformatics experts have worked closely with our clients to advance the technologies for protein optimization and production, enabling breakthrough develop
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.24 | 2026-10-16 | +3.63% | 0.520 |
| 1M | 1.38 | 2026-09-23 | -6.88% | 1.786 |
| 3M | 1.99 | 2026-07-23 | -35.43% | 1.083 |
| 6M | 2.52 | 2026-04-23 | -49.01% | 1.551 |
| 1Y | 2.59 | 2025-10-23 | -50.39% | 1.787 |
| 2Y | 3.06 | 2024-10-23 | -58.01% | — |
| 5Y | 29.75 | 2021-10-22 | -95.68% | 1.971 |
Codexis, Inc. (NASDAQ:CDXS) stock price today is $1.29, and today's volume is 422,708. CDXS is down 1.908% today. The 30 day average volume is 869,152. CDXS market cap is $140.71M with 109.51M shares outstanding.